U.S. markets closed

IGC Pharma, Inc. (IGC)

NYSE American - Nasdaq Real Time Price. Currency in USD
0.3027+0.0027 (+0.90%)
At close: 03:58PM EST
0.3083 +0.01 (+1.85%)
After hours: 07:57PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close0.3000
Bid0.3000 x 900
Ask0.3083 x 800
Day's Range0.3000 - 0.3083
52 Week Range0.2700 - 0.4900
Avg. Volume230,784
Market Cap19.292M
Beta (5Y Monthly)2.65
PE Ratio (TTM)N/A
EPS (TTM)-0.2000
Earnings DateFeb 12, 2024 - Feb 16, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for IGC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • IGC Pharma, Inc.
    VVI: Lowering target price to $27.00VIAD CORP has an Investment Rating of SELL; a target price of $27.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more